Evidence map›Paper›PMID 29675656›Full record

ArticleNanoscale research letters2018

Ligand-Doped Copper Oxo-hydroxide Nanoparticles are Effective Antimicrobials.

Carlos A P Bastos, Nuno Faria, Angela Ivask, Olesja M Bondarenko, Anne Kahru, Jonathan Powell

Open access · goldAbstract read
In one paragraph

Article in Nanoscale research letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Carlos A P BastosBiomineral Research Group, Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, UK. capb2@cam.ac.uk.ORCID http://orcid.org/0000-0003-3528-2178
Nuno FariaBiomineral Research Group, Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, UK. Nuno.Faria@mrc-ewl.cam.ac.uk.
Angela IvaskNational Institute of Chemical Physics and Biophysics, Laboratory of Environmental Toxicology, Akadeemia tee 23, 12618, Tallinn, Estonia. angela.ivask@kbfi.ee.
Olesja M BondarenkoNational Institute of Chemical Physics and Biophysics, Laboratory of Environmental Toxicology, Akadeemia tee 23, 12618, Tallinn, Estonia.
Anne KahruNational Institute of Chemical Physics and Biophysics, Laboratory of Environmental Toxicology, Akadeemia tee 23, 12618, Tallinn, Estonia.
Jonathan PowellBiomineral Research Group, Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, UK.
MRC Human Nutrition Research · GBNational Institute of Chemical Physics and Biophysics · EEEstonian Academy of Sciences · EE

Funding

NCI CLINICAL INVESTIGATOR AWARD PROGRAMK08CA001059 · NCI · WASHINGTON UNIVERSITY · PI CARROLL, WILLIAM L. · 1985 to 1987
–
Estonian Research Council IUT 23-5Estonian Research Council PUT1015Estonian Research Council PUT 748European Regional Development Fund project TK134Medical Research Council MR/R005699/1Medical Research Council (GB) MC_US_A090_0008/ Unit Programme number U1059
6 · The paper itself

Abstract

Bacterial resistance to antimicrobial therapies is an increasing clinical problem. This is as true for topical applications as it is for systemic therapy. Topically, copper ions may be effective and cheap antimicrobials that act through multiple pathways thereby limiting opportunities to bacteria for resistance. However, the chemistry of copper does not lend itself to facile formulations that will readily release copper ions at biologically compatible pHs. Here, we have developed nanoparticulate copper hydroxide adipate tartrate (CHAT) as a cheap, safe, and readily synthesised material that should enable antimicrobial copper ion release in an infected wound environment.First, we synthesised CHAT and showed that this had disperse aquated particle sizes of 2-5 nm and a mean zeta potential of - 40 mV. Next, when diluted into bacterial medium, CHAT demonstrated similar efficacy to copper chloride against Escherichia coli and Staphylococcus aureus, with dose-dependent activity occurring mostly around 12.5-50 mg/L of copper. Indeed, at these levels, CHAT very rapidly dissolved and, as confirmed by a bacterial copper biosensor, showed identical intracellular loading to copper ions derived from copper chloride. However, when formulated at 250 mg/L in a topically applied matrix, namely hydroxyethyl cellulose, the benefit of CHAT over copper chloride was apparent. The former yielded rapid sustained release of copper within the bactericidal range, but the copper chloride, which formed insoluble precipitates at such concentration and pH, achieved a maximum release of 10 ± 7 mg/L copper by 24 h.We provide a practical formulation for topical copper-based antimicrobial therapy. Further studies, especially in vivo, are merited.

Indexed as

Antibacterial activityBacterial biosensorCopperLabile nanoparticleNanoparticleTopical antimicrobial

Identifiers

PMID29675656
PMCPMC5908776
OpenAlexW2800981573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.